| 引用本文:张璇1，王培利2，柴华3，梁芳3，杨朔4，史大卓2.史大卓教授治疗急性心肌梗死的中医临床经验[J].世界中医药,2017,(06):. |
|
| 史大卓教授治疗急性心肌梗死的中医临床经验 |
| Shi Dazhuo’s Clinical Experience in Treating Acute Myocardial Infarction |
| 投稿时间：2017-03-03 |
| DOI：10.3969/j.issn.1673-7202.2017.06.043 |
| 中文关键词: 急性心肌梗死 中医药 @史大卓 经验 |
| English Keywords:Acute Myocardial Infarction （AMI） Traditional Chinese Medicine （TCM） Shi Dazhuo Experiences |
| 基金项目:国家自然科学基金面上项目（编号：81473528） |
|
| 摘要点击次数: 1109 |
| 全文下载次数: 967 |
| 中文摘要: |
| 急性心肌梗死（Acute Myocardial Infarction，AMI）的血运重建治疗和抗血小板、调脂药物的应用，显著改善了预后，但近晚期血栓形成、无/慢复流和支架内再狭窄等仍是严重影响预后重要问题。因此，如何中西医优势互补，进一步改善预后，仍是中医临床面临的一个挑战。史大卓教授在结合西医治疗的基础上，明辨AMI气血阴阳虚实之不同，根据病情的轻重缓急，在传统活血化瘀的基础上，注重“毒”邪致病这一病机特点，临证灵活应用益气、活血、化毒、生肌、通腑等法，获得良好疗效。 |
| English Summary: |
| Revascularization combined with anti-platelet and lipid-lowering drugs prominently improved the prognosis of patients with acute myocardial infarction （AMI）. However, early and long-term thrombosis, no/slow-reflow phenomenon and in-stent restenosis remain the major problems which impact on the prognosis of AMI patients. Therefore, how to take the complementary advantage of traditional Chinese medicine （TCM） and western medicine （WM） to further improve the prognosis is still a big challenge for TCM clinical practice. On a background of standard treatment, professor Shi performs well in differentiating TCM syndrome of patients with AMI and emphasizing pathogenic characteristics of toxin factors, and flexibly adopts the treatment of benefiting qi, activating blood, detoxifying, promoting myocardial tissue regeneration and purgation fu-organs, by which, certain good clinical has been achieved in the patients with AMI. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
